Acotec Scientific Holdings Limited (ACOTEC-B) reported no changes in its share capital structure for the month ended 30 April 2026, according to its latest submission to Hong Kong Exchanges and Clearing Limited.

Authorised Capital • Authorised share count remained at 10.00 billion ordinary shares with a par value of USD 0.00001, translating to total authorised capital of USD 100,000.

Issued Shares and Treasury Shares • Issued shares stood unchanged at 313.39 million. • The company held no treasury shares during the period. • Consequently, total issued share capital also remained at 313.39 million shares.

Public Float Compliance • Management confirmed compliance with the Main Board’s 25 % minimum public float requirement as of 30 April 2026.

Corporate Actions • No share options, warrants, convertible securities, or other equity-settled arrangements were exercised, granted, or cancelled during the month. • The Restricted Share Unit Scheme (adopted 8 January 2021) and the Share Award Scheme (adopted 31 December 2021) recorded no activity.

The filing, signed by Director Jing Li on 6 May 2026, indicates a stable capital base with no dilution or repurchase activity in April.